TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With HIV-1: ACTG A5357.

Babafemi O Taiwo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.